Longevity
Vilon
Immunity
2
Amino acids
Molecular weight
Peptide
Type
Vilon is a Khavinson bioregulator dipeptide (KE) consisting of lysine and glutamic acid, originally isolated from thymus gland extracts. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it acts as a molecular signaling compound that restores normal gene expression and protein synthesis in immune and epithelial cells. Research shows Vilon increases mean lifespan by 20-40% in animal studies and suppresses tumor development.
Vilon works through epigenetic modulation, restoring chromatin structure and gene expression in immune cells. It stimulates thymocyte proliferation, activates T-helper cells, and increases the proliferative index in thymus tissue (from 26% to 37% in studies). The peptide modulates tyrosine phosphorylation of mitogen-activated cytoplasmic kinases and helps rejuvenate aged immune systems by restoring proper gene expression patterns.
Oral capsules: room temperature; Lyophilized powder/reconstituted: 2-8°C refrigerated
Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
10-20 mg per day (oral capsules) or 10 mg (injectable)
10-20 day cycle (typical 10 days in research)
Increases mean lifespan 20-40% in animal models
Suppresses tumor development
Stimulates thymocyte proliferation
Activates T-helper cells
Restores chromatin structure in aged lymphocytes
Enhances intestinal barrier function
Improves enzyme activity in aged tissue
Part of comprehensive longevity protocols
This peptide is still gaining traction in the community.
KE Dipeptide | Thymus Immune Bioregulator
This overview is informational and based on aggregated descriptions from studies and user reports.
Was it helpful?YesView the scientifc details of Vilon.
2
Amino Acids
Vilon
Lys
Lys
Position 1
Glu
Glu
Position 2
Available in capsule form for oral administration. As the shortest Khavinson peptide (just 2 amino acids), Vilon is easily absorbed orally. Typical protocol involves 10-20 day cycles, repeated 2-3 times per year.
| Goal | Dosage | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10 | 10 week range | Oral capsules |
| Maintenance | 10 | 2 week range | Oral capsules |
The Vilon Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.
Taking breaks between cycles may help maintain effectiveness and support better overall results.
Dosing tools
Calculate peptide doses with our visual syringe guide.
0.3mL / 30 units
5 units
0.050 mL
1 mL
2 mL
3 mL
5 mL
Custom
Conversion: 1,000 mcg = 1 mg
Based on your vial and dilution inputs.
Safe concentration range
Vilon
SINGLE COMPOUNDVolume per injection
0.05
mL
Concentration
10.00
mg/mL
Doses per vial
20
doses
Total injections per vial
20 injections
How it works
Based on a 10 mg Vilon vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.
Research Purposes Only
These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.
Note: Triple agonist; microdose for fewer side effects
Research suggestions of Vilon interactions with other common peptides and substances.
Longevity
cry
Immunity
SYNERGISTIC
Both have immunoprotecting properties; different mechanisms.
Longevity
epi
Immunity
SYNERGISTIC
Often combined in comprehensive anti-aging Khavinson protocols.
Longevity
thy
Immunity
SYNERGISTIC
Both target thymus/immune system; complementary mechanisms.
Longevity
thym
Immunity
COMPATIBLE
Related immune peptides; can be used in comprehensive protocols.
Active autoimmune flares (consult physician)
Known hypersensitivity
Pregnancy or breastfeeding
Allergic reactions
Unusual immune symptoms
0.0
0 reviews
5
4
3
2
1
No comments yet
Be the first to share your experience. Your review helps others make more informed decisions.
Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.
Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.
Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.
Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.
Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.
Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.
Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.
Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.
Vilon is a moderate research compound
Vilon
Vilon is a moderate research compound
Peptide Bioregulators Increase Lifespan
Long-term treatment with peptide preparations including Vilon increased mean lifespan 20-40% and suppressed tumorigenesis.
n.d.
Vilon Effects on Aged Lymphocytes
Vilon improved lymphocytes from old people by restoring chromatin structure and gene expression.
n.d.
Peptides Regulating Proliferative Activity in THP-1 Cells
Vilon and other Khavinson peptides modulate key proliferative patterns and tyrosine phosphorylation of kinases.
n.d.
Short Peptide Immunoprotecting Properties
Vilon and related peptides possess age-associated immunoprotecting properties in the spleen.
n.d.